Simplex Trading’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.55K Sell
100
-5,000
-98% -$269K ﹤0.01% 7823
2025
Q4
$247K Sell
5,100
-9,900
-66% -$386K ﹤0.01% 4012
2025
Q3
$459K Buy
15,000
+13,700
+1,054% +$314K ﹤0.01% 3934
2025
Q2
$28K Sell
1,300
-4,500
-78% -$94.2K ﹤0.01% 6452
2025
Q1
$107K Sell
5,800
-195,800
-97% -$3.27M ﹤0.01% 4987
2024
Q4
$2.67M Buy
201,600
+195,100
+3,002% +$4.73M ﹤0.01% 1955
2024
Q3
$217K Buy
+6,500
New +$222K ﹤0.01% 4437
2024
Q2
Sell
-200
Closed -$4K 8700
2024
Q1
$4K Hold
200
﹤0.01% 8078
2023
Q4
$4K Buy
+200
New +$3.45K ﹤0.01% 7930
2023
Q1
Sell
-700
Closed -$21K 8930
2022
Q4
$21K Hold
700
﹤0.01% 6818
2022
Q3
$17K Buy
+700
New +$16.4K ﹤0.01% 7663
2021
Q4
Sell
-600
Closed -$15K 10396
2021
Q3
$15K Hold
600
﹤0.01% 8651
2021
Q2
$15K Buy
600
+57
+10% +$1.37K ﹤0.01% 8809
2021
Q1
$1.17M Buy
543
+536
+7,657% +$13.5K ﹤0.01% 2221
2020
Q4
$15K Buy
+7
New +$170 ﹤0.01% 7148
2020
Q3
Sell
-1
Closed -$2K 7721
2020
Q2
$2K Sell
1
-432
-100% -$7.9K ﹤0.01% 7219
2020
Q1
$611K Sell
433
-253
-37% -$3.84K ﹤0.01% 2388
2019
Q4
$1.11M Buy
686
+683
+22,767% +$16.2K ﹤0.01% 1995
2019
Q3
$10K Sell
3
-79
-96% -$3.76K ﹤0.01% 6233
2019
Q2
$462K Buy
82
+56
+215% +$4.03K ﹤0.01% 2635
2019
Q1
$189K Buy
26
+24
+1,200% +$1.66K ﹤0.01% 3679
2018
Q4
$12K Sell
2
-309
-99% -$23K ﹤0.01% 5708
2018
Q3
$3.1M Buy
311
+306
+6,120% +$25.4K 0.01% 913
2018
Q2
$35K Sell
5
-2
-29% -$168 ﹤0.01% 5406
2018
Q1
$13K Buy
+7
New +$789 ﹤0.01% 3758

Other funds holding ANAB

Simplex Trading's ANAB Position: Q4 2024 in Review

Simplex Trading sold out of AnaptysBio (ANAB) in Q4 2024, closing a stake of 3,423 shares — an estimated $82.9K sold.

Simplex Trading first reported a position in ANAB in Q1 2018 and held it in 13 quarters. The position peaked at $332K in Q1 2021. 135 funds tracked by Wall St. Rank hold ANAB as of Q4 2024.

  • Simplex Trading reported no remaining AnaptysBio position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 3,423 AnaptysBio shares in Q4 2024, an estimated $82.9K.
  • Simplex Trading first reported a position in AnaptysBio in Q1 2018 and held it in 13 quarters.
  • Simplex Trading's AnaptysBio position peaked at $332K in Q1 2021.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.